Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report
Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 2, 2021
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
Qing Li, Zhi-Wei Zhou, Wei Duan, et al.
Molecular Oncology
|
January 22, 2025
Oncogenic mutant KRAS inhibition through oxidation at cysteine 118
Maximilian Kramer-Drauberg, Ettore Petrini, Alessia Mira, et al.
Journal of Medicinal Chemistry
|
January 15, 2020
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Guangyan Du, Suman Rao, Deepak Gurbani, et al.
Plos Biology
|
June 2, 2021
The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51
Jung Mi Park, Seung Wook Yang, Wei Zhuang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2025
Global Longitudinal Strain: A Potential Noninvasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Patients With Lung Cancer Receiving Thoracic Radiation Therapy
Steven K Montalvo, Brian Lue, Eugenia Kakadiaris, et al.
Eclinicalmedicine
|
October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial
Sagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
Cancer Research
|
July 2, 2020
KRAS<sup>Q61H</sup> Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non-Small Cell Lung Cancer
Zhi-Wei Zhou, Chiara Ambrogio, Asim K Bera, et al.
Cell
|
January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial
Yuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report
Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 2, 2021
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
Qing Li, Zhi-Wei Zhou, Wei Duan, et al.
Molecular Oncology
|
January 22, 2025
Oncogenic mutant KRAS inhibition through oxidation at cysteine 118
Maximilian Kramer-Drauberg, Ettore Petrini, Alessia Mira, et al.
Journal of Medicinal Chemistry
|
January 15, 2020
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Guangyan Du, Suman Rao, Deepak Gurbani, et al.
Plos Biology
|
June 2, 2021
The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51
Jung Mi Park, Seung Wook Yang, Wei Zhuang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2025
Global Longitudinal Strain: A Potential Noninvasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Patients With Lung Cancer Receiving Thoracic Radiation Therapy
Steven K Montalvo, Brian Lue, Eugenia Kakadiaris, et al.
Eclinicalmedicine
|
October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial
Sagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
Cancer Research
|
July 2, 2020
KRAS<sup>Q61H</sup> Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non-Small Cell Lung Cancer
Zhi-Wei Zhou, Chiara Ambrogio, Asim K Bera, et al.
Cell
|
January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Chiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial
Yuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, et al.
Page
of 10